Hunter Williams
→ profileProtocol systematizer
Cautions
- Hunter Williams: "I don't think that's a path that everyone needs to go down." [Peptide Q&A · March 2026 | 2026-04-30 | @ 10:42 |
- Hunter Williams: "So again, this was mRNA delivery and it was a bioactive product is endogenous folestatin protein. Again, a little bit different than the injection of folostatin but mechanistically it seems like it's doing positive things. And again that was the 2022 study in mice." [Peptide Cancer Claims Debunked | 20+ Studies Analyzed | 2026-05-25 | @ 11:57 |
- Hunter Williams: "Obviously, these are not FDA approved cancer therapy. So I'm not telling you to do these. Obviously these were things that have not been replicated to scale whatsoever. And again, just because it's preclinical does not mean that it is recommendation." [Peptide Cancer Claims Debunked | 20+ Studies Analyzed | 2026-05-25 | @ 26:37 |
Taylor Williams
→ profileFemale-focused HRT + peptides
No content captured for this peptide from this expert.
Dr Trevor Bachmeyer
→ profileAcute vs chronic specialist
No content captured for this peptide from this expert.
Ask the Follistatin 344 Librarian
Answers cite Hunter Williams, Taylor Williams, and Dr Trevor Bachmeyer only — no invented content.
Ask a question about Follistatin 344: dosing, timing, female-specific considerations, acute vs chronic context, stacking, contraindications.
Research educational use only. Not medical advice. Citations only — no invented content.
Disclaimer — For Research Purposes Only
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol. Members who want access can read about the member-owned co-op on our co-op page.